Pfizer-BioNTech vaccine deliveries could start 'before Christmas'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. KNX
10. QGEN

Go back to Pfizer-BioNTech vaccine deliveries could start 'before Christmas'

Wells Fargo Reiterates Overweight Rating on Johnson & Johnson (JNJ)

November 19, 2020 6:46 AM EST

Wells Fargo analyst Larry Biegelsen reiterated an Overweight rating and $172.00 price target on Johnson & Johnson (NYSE: JNJ) following the company's virtual booth tour, ahead of its analyst day.

On its Q3 call, JNJ indicated that it expected Q4 MD recovery to continue with... More

Pfizer (PFE), BioNTech (BNTX) Confirm Phase 3 Study of COVID-19 Vaccine Candidate Shows 95% Efficacy

November 18, 2020 7:00 AM EST

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that, after conducting the final efficacy analysis in their ongoing Phase 3 study, their mRNA-based COVID-19 vaccine candidate, BNT162b2, met all of the studys primary efficacy endpoints. Analysis of the data indicates a vaccine efficacy rate of 95% (p... More